Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world Safety and Effectiveness of Diazepam Nasal Spray in Children with Epilepsy
ChiCTR2400091512Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of diazepam in epilepsy, sponsored by Children's Hospital of Fudan University. Primary endpoint: Adverse events within 28 days after diazepam nasal spray administration. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
diazepam
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2400091512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091512.